Outcomes after novel transcatheter and surgical tricuspid valve interventions

Session comprising selected 2021 PCR London Valves Abstract submissions

Presenters: J. Dreyfus, M. Eleid, M. Gerçek, R. Makkar, G. Nickenig, A. Patrascu, M. Wild

Summary

Find out more about TRI-SCORE, a new risk score to predict in-hospital mortality after isolated tricuspid valve surgery, 30-day outcomes for transcatheter tricuspid repair from the TriBAND study, both the CLASP TR early feasibility and TRISCEND studies six-month results, and more in this PCR London Valves 2021 session dedicated to the tricuspid valve.

Presentations available when logged in:

TRI-SCORE: a new risk score to predict in-hospital mortality after isolated tricuspid valve surgery
Assessment of right heart remodeling following interventional tricuspid valve treatment
Early experience: new transcatheter leaflet repair system for treatment of tricuspid regurgitation
Transthoracic echocardiography guidance of percutaneous tricuspid valve repair: a pilot study
30-day outcomes for transcatheter tricuspid repair from the TriBAND study
Transcatheter tricuspid valve repair: CLASP TR early feasibility study six-month results
Transfemoral tricuspid valve replacement in patients with TR: the TRISCEND study six-month outcomes

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Outcomes after novel transcatheter and surgical tricuspid valve interventions

Session comprising selected 2021 PCR London Valves Abstract submissions

Log in or create account for free